|
|
|
|
|
12.02.26 - 09:09
|
Aktien Asien: Durchwachsene Entwicklung (DPA-AFX)
|
|
|
TOKIO/SHANGHAI/HONGKONG/SYDNEY (dpa-AFX) - Die asiatischen Börsen haben sich am Donnerstag uneinheitlich entwickelt. Sie folgten damit den durchwachsenen Vorgaben aus den USA.Die soliden US-Arbeitsmarktdaten hatten Zinshoffnungen gedämpft. ......
|
|
|
|
|
12.02.26 - 01:54
|
Win Streak May End For China Stock Market (AFX)
|
|
|
BEIJING (dpa-AFX) - The China stock market has finished higher in three straight sessions, collecting more than 65 points or 1.6 percent along the way. The Shanghai Composite Index now sits just a......
|
|
|
12.02.26 - 00:36
|
Index compiler MSCI tilts towards Chinese tech stocks in latest revamp (SCMP)
|
|
|
Global index provider MSCI revised its China gauge on Wednesday, swapping property and conglomerates for semiconductor and artificial intelligence stocks in a sign of technology's rising role in the economy.
The MSCI China Index added tech stocks including SenseTime, Pony.ai and Hesai Technology for a second straight quarter of net constituent growth since late 2025, a move analysts said would accelerate capital flows into the country's technology sector.
Against a macro backdrop of a relatively......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.02.26 - 09:09
|
Aktien Asien: Deutliche Anschlussgewinne in Japan (DPA-AFX)
|
|
|
TOKIO/SHANGHAI/HONGKONG/SYDNEY (dpa-AFX) - Die asiatischen Börsen haben am Dienstag zumeist zugelegt. Von Japan abgesehen, hielten sich die Bewegungen allerdings in Grenzen. Die Börsen folgten mit ihrem Anstieg den Vorgaben der US-Technologiewerte. Hier ......
|
|
|
10.02.26 - 06:06
|
Chinese investors pour into Hong Kong-listed drug stocks as international deals multiply (SCMP)
|
|
|
Chinese onshore investors raised their investments in Hong Kong-listed drug makers through the cross-border trading link over the past week, as a wave of out-licensing deals between Chinese pharmaceutical firms and global partners rolls on.
The Hang Seng Southbound Connect Hong Kong Innovative Drug Index, which tracks around 40 of the largest Hong Kong-listed Chinese drug manufacturers, biotech researchers and AI-driven drug developers by market capitalisation, rose about 9 per cent between......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|